HIMS250509C42500
- 9.50
- +1.95+25.83%
Hims & Hers Health Newsroom
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Hims & Hers Health Options Spot-On: On May 7th, 329.78K Contracts Were Traded, With 840.58K Open Interest
Alphabet Leaps Over Nvidia, Tesla in Top Stock Options as AI Threatens Search Revenue: Options Chatter
Leerink Partners Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $42
Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took It By Surprise -- Barrons.com
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%
Novo Nordisk Cuts 2025 Outlook. But Why Are Its Shares Rising?
Express News | Hims & Hers : Deutsche Bank Raises Target Price to $43 From $38
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Wednesday; AMD to Advance, Super Micro to Decline
Trending Stocks Today | NetClass Technology Shoots up 42.45% Pre-Market
Hims & Hers Health Options Spot-On: On May 6th, 697.94K Contracts Were Traded, With 749.91K Open Interest
Hims & Hers Health Up Over 17%, on Track for Longest Winning Streak Since February -- Data Talk
Hims & Hers Health Has a Range of Strategies It Can Pursue -- Market Talk
Tesla, Palantir, Hims & Hers, Ford, DoorDash, SolarEdge, Vertex: Biggest Movers
Trending Stocks Today | FOXO Technologies Surges 148.38%
10 Health Care Stocks With Whale Alerts In Today's Session
Hims & Hers Joins Nvidia, Tesla, Apple in Most Active Stock Options: Options Chatter
Is Hims & Hers Health Stock (HIMS) the Target of a Meme-Driven Short Squeeze?
Express News | Citigroup Maintains Sell on Hims & Hers Health, Raises Price Target to $30
Hims & Hers Stock Gains 15%+ After Earnings Even Though the Sales Outlook Looks Low